Rubric Capital Management (New York)’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,406,449
| Closed | -$3.85M | – | 75 |
|
|
2022
Q4 | $3.85M | Hold |
2,406,449
| – | – | 0.17% | 76 |
|
|
2022
Q3 | $3.49M | Hold |
2,406,449
| – | – | 0.18% | 72 |
|
|
2022
Q2 | $4.4M | Hold |
2,406,449
| – | – | 0.23% | 65 |
|
|
2022
Q1 | $6.43M | Hold |
2,406,449
| – | – | 0.23% | 54 |
|
|
2021
Q4 | $10.4M | Buy |
+2,406,449
| New | +$10.4M | 0.49% | 46 |
|